Post

Cullinan advances multiple myeloma drug CLN-619 to a Phase I study

Cullinan Oncology is gearing up to advance one of its lead drugs CLN-619 into a Phase I clinical study for …

Panama updates their medicine regulatory system

Law 419/2024, passed by the president on 1 February 2024, was created to guarantee the supply of medicines through centralised …

Biotech funding optimism rises as 44% predict recovery in 2024

GlobalData’s recent survey The State of the Biopharmaceutical Industry 2024 revealed that 44% of healthcare industry professionals surveyed globally are …

Green granulation: Tracking energy efficiency in pharmaceutical granulation

According to a recent poll of Pharmaceutical Technology readers (conducted by GlobalData)[i] 43% of respondents said that environmental issues were …

Market cap upturn for top 20 biopharma companies with obesity drug successes in 2023

The top 20 biopharmaceutical companies saw prominent shifts in market capitalisation over 2023 despite macroeconomic challenges, upcoming patent cliffs, and …